NCT00426283View on ClinicalTrials.gov

A Study of Flovent in Patients With Eosinophilic Esophagitis

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2012

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

Flovent

1760 mcg daily

OTHER

Placebo

Placebo

Trial Locations (4)

19104

Children's Hospital of Philadelphia, Philadelphia

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

80045

The Children's Hospital of Denver, Aurora

84132

University of Utah, Salt Lake City

All Listed Sponsors
lead

Marc Rothenberg, MD

OTHER

NCT00426283 - A Study of Flovent in Patients With Eosinophilic Esophagitis | Biotech Hunter | Biotech Hunter